Scientific publications

Metabolic Brain Disease, 2024

Individuals with SATB2-associated syndrome have impaired vitamin and energy metabolism pathways

Collu R., Zarate Y., Xia W. et al.

Transfusion and Apheresis Science, 2024

Mechanistic insights from a pilot exploratory study of the dynamic proteomic changes during plasma exchange in patients with acute liver failure

Jauniaux B., Burke L., Snook N. et al.

Circulation, 2024

A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia

Ho F., Mark P., Lees J. et al.

Frontiers in Immunology, 2024

A targeted proteomics screen reveals serum and synovial fluid proteomic signature in patients with gout

Huang Z., Zhong X., Zhang Y. et al.

Neurology Neuroimmunology & Neuroinflammation, 2024

Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis

Held F., Makarov C., Gasperi C. et al.

Science Translational Medicine, 2024

Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution

Hamlin R., Pienkos S., Chan L. et al.

GeroScience, 2024

Plasma proteomic signature of risk and prognosis of frailty in the UK Biobank

Xu J., Liu J., Tang J. et al.

Journal of Leukocyte Biology, 2024

Interleukin-10 inhibits important components of trained immunity in human monocytes

Röring R., Scognamiglio F., de Jong L. et al.

Journal of Stroke and Cerebrovascular Diseases, 2024

Sodium-glucose cotransporter protein 2 inhibition, plasma proteins, and ischemic stroke: A mediation Mendelian randomization and colocalization study

Chen Z., Meng H., Guo Y. et al.

GeroScience, 2024

Plasma proteomics-based brain aging signature and incident dementia risk

Kou M., Ma H., Wang X. et al.

EPMA Journal, 2024

Mendelian randomization reveals predictive, preventive, and personalized insights into inflammatory bowel disease: the role of gut microbiome and circulating inflammatory proteins

Zhao W., Li S., Li Q. et al.

British Journal of Nutrition, 2024

The protective effect of higher serum triacylglycerol (51:4) levels against Parkinson’s disease

Jing Y., Su J., Zhu H. et al.

BJPsych Open, 2024

Depression in childhood to early adulthood and respiratory health in early adulthood

Wang G., Hallberg J., Hernandez-Pacheco N. et al.

Frontiers in Molecular Biosciences, 2024

Proteomics analysis of extracellular vesicles for biomarkers of autism spectrum disorder

Ali Moussa H., Shin K., de la Fuente A. et al.

Molecular Neurodegeneration, 2024

CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals

del Campo M., Quesada C., Vermunt L. et al.

Journal of the Neurological Sciences, 2024

Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis

Kornilov S., Price N., Gelinas R. et al.

Journal of Translational Medicine, 2024

Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients: a cohort study

Zhong B., King B., Waziri H. et al.

Nature Medicine, 2024

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Li R., Villa N., Yu X. et al.

Nature Communications, 2024

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

Martins T., Kaymak D., Tatari N. et al.

American Journal of Respiratory and Critical Care Medicine, 2024

Unsupervised Classification of the Host Response Identifies Dominant Pathobiological Signatures of Sepsis in Sub-Saharan Africa

Cummings M., Lutwama J., Owor N. et al.